CBD (CBDBY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Morningstar’s Lee noted that office demand slipped “slightly” in the third quarter of 2025, as occupants prioritised lease ...

Silentnight's Night Light & Sound Machine lands at Lidl next week and has tons of colour and sound options to make bedtime ...

A Sydney couple have explained their decision to buy their young child a $370,000 apartment, with the toddler becoming a ...

A three-year-old from Western Sydney has become one of Australia’s youngest property owners after her parents used birthday ...

Wednesday night’s Powerball drawing went without a jackpot winner, pushing the top prize to an estimated $1 billion for Saturday. It’s the second largest of this year, lagging ...

The Northern Territory has more suburbs in the 2026 Hot 100 than in the previous three years combined. Millner and Rapid ...

A new AP-NORC poll finds this holiday season isn’t quite so merry for American shoppers as large shares of them are dipping ...

For hemp producers, entering the carbon credit market may provide a strategy for long-term sustainability and market ...

Property renovator Chris Bye has listed his latest home flip in The Central Coast and could stand to pocket close to $1.2m ...

HERZLIYA, Israel and CALGARY, AB, Dec. 10, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further ...

An announcement from Living Cell Technologies ( ($AU:1AI) ) is now available. Algorae Pharmaceuticals has announced the ...